Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study for Measuring the Effect of Antiepileptic Drugs on Mitochondrial Activity

NCT01218321 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01218321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study for Measuring the Effect of Antiepileptic Drugs on Mitochondrial Activity
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
June 30, 2012
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy